PAD 133 (Hydrochlorothiazide and Moexipril Hydrochloride 12.5 mg / 7.5 mg)
Pill with imprint PAD 133 is Yellow, Elliptical / Oval and has been identified as Hydrochlorothiazide and Moexipril Hydrochloride 12.5 mg / 7.5 mg. It is supplied by Paddock Laboratories, Inc..
Hydrochlorothiazide/moexipril is used in the treatment of high blood pressure and belongs to the drug class ACE inhibitors with thiazides. There is positive evidence of human fetal risk during pregnancy. Hydrochlorothiazide/moexipril 12.5 mg / 7.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for PAD 133
Hydrochlorothiazide and Moexipril Hydrochloride
- Imprint
- PAD 133
- Strength
- 12.5 mg / 7.5 mg
- Color
- Yellow
- Size
- 11.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Ace inhibitors with thiazides
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Paddock Laboratories, Inc.
- National Drug Code (NDC)
- 00574-0133
- Inactive Ingredients
-
lactose,
magnesium oxide,
crospovidone,
magnesium stearate,
povidone,
silicon dioxide,
hypromelloses,
titanium dioxide,
polyethylene glycol 400,
ferric oxide red
Note: Inactive ingredients may vary.
More about hydrochlorothiazide / moexipril
- Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- 1 Review
- Drug class: ACE inhibitors with thiazides
- FDA Alerts (1)
Consumer resources
- Other brands
- Uniretic
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.